Deborah A. Thomas

35.7k citations

451 papers · 23.2k indexed · 6 hit papers · h-index 80

Impact in

Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Genetics 246
- Chronic Lymphocytic Leukemia Research 191
- Myeloproliferative Neoplasms: Diagnosis and Treatment 47
Hematology 250
- Chronic Myeloid Leukemia Treatments 136
- Acute Myeloid Leukemia Research 126
- Multiple Myeloma Research and Treatments 29

Co-authors: Hagop M. Kantarjian Jörge E. Cortes Susan O’Brien Francis J. Giles Stefan Faderl Guillermo Garcia‐Manero Michael J. Keating Srđan Verstovšek
Journals: Blood (194 papers)Cancer (56 papers)Journal of Clinical Oncology (46 papers)British Journal of Haematology (11 papers)Leukemia Research (8 papers)
Partner nations: United States United Kingdom Australia

In The Last Decade

Deborah A. Thomas

442 papers receiving 22.7k citations

Hit Papers

6 papers align trajectories log scale

Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis 2010 · 847 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 New England Journal of Medicine
2008 Blood
2006 New England Journal of Medicine
2005 Journal of Clinical Oncology
2003 Blood
2000 Blood

Peers

Countries citing papers authored by Deborah A. Thomas

Since Specialization

Citations

This map shows the geographic impact of Deborah A. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah A. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah A. Thomas more than expected).

Fields of papers citing papers by Deborah A. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah A. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah A. Thomas. The network helps show where Deborah A. Thomas may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Deborah A. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deborah A. Thomas Line = papers co-authored together Deborah A. Thomas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Adultification of Young Black Females on Their Health and Well-being: A Qualitative Study PEDIATRICS ·仁美柳瀬, Францина Евгения Владимировна, A ちc, 美樹本橋, Jane Marsden, Cathryn Knight, 木村映善, 曹翠荣, Joanna L. Williams, Deborah A. Thomas, Gavin J Cressy, Kenneth R. Ginsburg, Nadia Dowshen	2025	0
2	Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease Crohn s & Colitis 360 ·Quazim A. Alayo, Ahmed M Khamiss, Osama Altayar, Kerri Glassner, Ernesto M. Llano, Kindra Clark‐Snustad, Anish Patel, Kenneth Patrick, Andrés Yarur, Benjamin L. Cohen, Matthew A. Ciorba, Deborah A. Thomas, Scott D. Lee, Edward V. Loftus, David Fudman, Bincy Abraham, Jean‐Frédéric Colombel, Parakkal Deepak	2022	57
3	Providing Information-Seeking Skills Feedback Within a Medical School Curriculum: A Partnership between Librarians and Education Specialists Medical Reference Services Quarterly ·Deborah A. Thomas, Angela Hardi, Houda Bensiradj	2020	1
4	Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia Haematologica ·Naval Daver, Deborah A. Thomas, Farhad Ravandi, Jörge E. Cortes, Rebecca Garris, Elias Jabbour, Guillermo Garcia‐Manero, Gautam Borthakur, Tapan M. Kadia, Michael Rytting, Marina Konopleva, Hagop M. Kantarjian, Susan O’Brien	2015	171
5	Opera in the Age of Rousseau: Music, Confrontation, Realism Opera in the Age of Rousseau: Music, Confrontation, Realism . By D avid C harlton . (Cambridge Studies in Opera). Cambridge: Cambridge University Press, 2013. xxii + 414 pp., ill. French Studies ·Deborah A. Thomas	2014	4
6	CD30 expression in acute lymphoblastic leukemia as assessed by flow cytometry analysis Leukemia & lymphoma ·Wenli Zheng, L. Jeffrey Medeiros, Ken H. Young, Maitrayee Goswami, T Rainville, Qian Rou, Deborah A. Thomas, Jörge E. Cortes, Sa A. Wang	2013	28
7	A phase 1‐2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high‐risk myelodysplastic syndrome Cancer ·Elias Jabbour, Hagop M. Kantarjian, Farhad Ravandi, Guillermo Garcia‐Manero, Zeev Estrov, Srđan Verstovšek, Susan O’Brien, Stefan Faderl, Deborah A. Thomas, James R. Wright, Jörge E. Cortes	2010	32
8	A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome Blood ·Stefan Faderl, Farhad Ravandi, Xuelin Huang, Guillermo Garcia‐Manero, Alessandra Ferrajoli, Zeev Estrov, Gautam Borthakur, Srđan Verstovšek, Deborah A. Thomas, Monica Kwari, Hagop M. Kantarjian	2008	151
9	Epigenetics of Acute Lymphocytic Leukemia Seminars in Hematology ·Guillermo Garcia‐Manero, Hui Yang, Shao-Qing Kuang, Susan O’Brien, Deborah A. Thomas, Hagop M. Kantarjian	2008	61
10	The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia Cancer ·Ahmed Aribi, Hagop M. Kantarjian, Charles Koller, Deborah A. Thomas, Stefan Faderl, Guillermo Garcia‐Manero, Jörge E. Cortes	2008	10
11	Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure Cancer ·Jörge E. Cortes, Alfonso Quintás‐Cardama, Guillermo Garcia‐Manero, Susan O’Brien, Dan Jones, Stefan Faderl, Amr Keleg, Francis J. Giles, Deborah A. Thomas, Hagop M. Kantarjian	2007	31
12	New approaches to the management of Philadelphia chromosome-positive acute lymphocytic leukemia Current Hematologic Malignancy Reports ·Deborah A. Thomas, Susan O’Brien, Jörge E. Cortes, Hagop M. Kantarjian	2007	1
13	Proteomic‐based prediction of clinical behavior in adult acute lymphoblastic leukemia Cancer ·Maher Albitar, Steven J. Potts, Francis J. Giles, Susan O’Brien, Michael J. Keating, Deborah A. Thomas, Charlotte H. Clarke, Iman Jilani, Christine Aguilar, Elihu H. Estey, Hagop M. Kantarjian	2006	25
14	Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion New England Journal of Medicine ·Alan F. List, Gordon W. Dewald, John M. Bennett, Aristoteles Giagounidis, Azra Raza, Eric J. Feldman, Bayard L. Powell, Peter L. Greenberg, Deborah A. Thomas, Richard M. Stone, Craig B. Reeder, Kenton Wride, John Patin, M. Schmidt, Jerome B. Zeldis, Robert Knight Hit paper breakdown →	2006	893
15	Antileukemic Activity and Pharmacodynamics of Intravenous Forodesine (BCX-1777), a Novel Purine Nucleoside Phosphorylase (PNP) Inhibitor, in Phase I/II Trials in Patients with Advanced T-Cell Malignancies. Blood ·Luis Isola, Richard R. Furman, Varsha Gandhi, Deborah A. Thomas, John Bennett, Shanta Bantia, J. Michael Kilpatrick	2004	11
16	Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy Cancer ·Gloria Mattiuzzi, Hagop M. Kantarjian, Stefan Faderl, JoAnn Lim, Dimitrios P. Kontoyiannis, Deborah A. Thomas, William G. Wierda, I. Raad, Guillermo Garcia‐Manero, Xian Zhou, Alexandra Ferrajoli, N. Bekele, Elihu H. Estey	2004	30
17	Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience Annals of Oncology ·Apostolia M. Tsimberidou, Frank Giles, I. Khouri, Carlos E. Bueso‐Ramos, Susan R. Pilat, Deborah A. Thomas, Jörge E. Cortes, Razelle Kurzrock	2004	38
18	Phase I study of oral topotecan in hematological malignancies. PubMed ·Miloslav Beran, Susan O’Brien, Deborah A. Thomas, Hai T. Tran, Jörge E. Cortes, Francis J. Giles, Elihu H. Estey, Hagop M. Kantarjian	2003	9
19	Primary refractory and relapsed adult acute lymphoblastic leukemia Cancer ·Deborah A. Thomas, Hagop M. Kantarjian, Terry L. Smith, Charles Koller, Jörge E. Cortes, Susan O’Brien, Francis J. Giles, James Gajewski, Sherry Pierce, Michael J. Keating	1999	144
20	Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications Leukemia ·达流, Stefan Faderl, Deborah A. Thomas, Jörge E. Cortes, Stephen J. O’Brien, Fadi Nasr, Sherry Pierce, William N. Huss, Armand B. Glassman, Michael J. Keating, HM Kantarjian	1999	20

About Deborah A. Thomas

Deborah A. Thomas is a scholar working on Genetics, Hematology, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Oncology, having authored 451 papers that have together received 23.2k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (198 papers), Chronic Lymphocytic Leukemia Research (191 papers), Chronic Myeloid Leukemia Treatments (136 papers), Acute Myeloid Leukemia Research (126 papers), Lymphoma Diagnosis and Treatment (93 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (47 papers), Multiple Myeloma Research and Treatments (29 papers) and Eosinophilic Disorders and Syndromes (28 papers). The work is most often cited by research in Hematology (12.3k citations), Genetics (10.2k citations), Pathology and Forensic Medicine (5.5k citations), Public Health, Environmental and Occupational Health (5.7k citations) and Oncology (4.9k citations). Deborah A. Thomas has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Hagop M. Kantarjian, Jörge E. Cortes, Susan O’Brien, Francis J. Giles, Stefan Faderl, Guillermo Garcia‐Manero, Michael J. Keating, Srđan Verstovšek, Maher Albitar and Charles Koller. Their work appears in journals such as Blood, Cancer, Journal of Clinical Oncology, British Journal of Haematology and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact